Clal Insurance Enterprises Holdings Ltd Sells 896,000 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Clal Insurance Enterprises Holdings Ltd reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 62.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 534,000 shares of the exchange traded fund’s stock after selling 896,000 shares during the period. Clal Insurance Enterprises Holdings Ltd owned about 0.70% of SPDR S&P Biotech ETF worth $48,092,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of XBI. Golden State Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth approximately $29,000. Kohmann Bosshard Financial Services LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $29,000. Avior Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the period. Tidemark LLC boosted its holdings in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the period. Finally, Quintet Private Bank Europe S.A. bought a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at $40,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $88.71 on Friday. The firm has a fifty day moving average price of $91.00 and a two-hundred day moving average price of $95.75. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company has a market cap of $5.85 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.